Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Lane

Showing results (71-80 of 235) with videos related to

Pageof 24
Sort By:
Proteins|June 19, 2016
Reactivation of mutant p53: Constraints on mechanism highlighted by principal component analysis of the DNA binding domainZahra Ouaray, Karim M ElSawy, David P Lane, et al.
The Journal of Physical Chemistry. B|December 25, 2015
Recognition Dynamics of p53 and MDM2: Implications for Peptide DesignKarim M ElSawy, David P Lane, Chandra S Verma, et al.
Nature Reviews. Cancer|November 26, 2009
Awakening guardian angels: drugging the p53 pathwayChristopher J Brown, Sonia Lain, Chandra S Verma, et al.
Cell Cycle (Georgetown, Tex.)|January 14, 2015
A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2Karim M ElSawy, Adelene Sim, David P Lane, et al.
Biosensors & Bioelectronics|April 25, 2013
A generic scaffold for conversion of peptide ligands into homogenous biosensorsSaurabh R Nirantar, Kun Song Yeo, Sharon Chee, et al.
BMC Biology|May 24, 2019
Monitoring flux in signalling pathways through measurements of 4EBP1-mediated eIF4F complex assemblyYuri Frosi, Rachael Usher, Dawn Thean Gek Lian, et al.
EJNMMI Research|April 18, 2020
Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2Anja C L Mortensen, Eric Morin, Christopher J Brown, et al.
Cell Cycle (Georgetown, Tex.)|September 25, 2007
Substrate specificity of cyclins determined by electrostaticsHui Jun Lee, Gek Huey Chua, Arun Krishnan, et al.
Cell Cycle (Georgetown, Tex.)|March 2, 2010
Differential binding of p53 and nutlin to MDM2 and MDMX: computational studiesThomas Leonard Joseph, Arumugam Madhumalar, Christopher J Brown, et al.
The Journal of Biological Chemistry|December 23, 2008
Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53Saurabh Dayal, Alison Sparks, Jimmy Jacob, et al.
Pageof 24

Showing results (71-80 of 235) with videos related to

Sort By:
Pageof 24
Proteins|June 19, 2016
Reactivation of mutant p53: Constraints on mechanism highlighted by principal component analysis of the DNA binding domainZahra Ouaray, Karim M ElSawy, David P Lane, et al.
The Journal of Physical Chemistry. B|December 25, 2015
Recognition Dynamics of p53 and MDM2: Implications for Peptide DesignKarim M ElSawy, David P Lane, Chandra S Verma, et al.
Nature Reviews. Cancer|November 26, 2009
Awakening guardian angels: drugging the p53 pathwayChristopher J Brown, Sonia Lain, Chandra S Verma, et al.
Cell Cycle (Georgetown, Tex.)|January 14, 2015
A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2Karim M ElSawy, Adelene Sim, David P Lane, et al.
Biosensors & Bioelectronics|April 25, 2013
A generic scaffold for conversion of peptide ligands into homogenous biosensorsSaurabh R Nirantar, Kun Song Yeo, Sharon Chee, et al.
BMC Biology|May 24, 2019
Monitoring flux in signalling pathways through measurements of 4EBP1-mediated eIF4F complex assemblyYuri Frosi, Rachael Usher, Dawn Thean Gek Lian, et al.
EJNMMI Research|April 18, 2020
Enhancing the therapeutic effects of in vitro targeted radionuclide therapy of 3D multicellular tumor spheroids using the novel stapled MDM2/X-p53 antagonist PM2Anja C L Mortensen, Eric Morin, Christopher J Brown, et al.
Cell Cycle (Georgetown, Tex.)|September 25, 2007
Substrate specificity of cyclins determined by electrostaticsHui Jun Lee, Gek Huey Chua, Arun Krishnan, et al.
Cell Cycle (Georgetown, Tex.)|March 2, 2010
Differential binding of p53 and nutlin to MDM2 and MDMX: computational studiesThomas Leonard Joseph, Arumugam Madhumalar, Christopher J Brown, et al.
The Journal of Biological Chemistry|December 23, 2008
Suppression of the deubiquitinating enzyme USP5 causes the accumulation of unanchored polyubiquitin and the activation of p53Saurabh Dayal, Alison Sparks, Jimmy Jacob, et al.
Pageof 24